Fastenal Posts Downbeat Earnings, Joins Vince Holding And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Fastenal Company (NASDAQ:FAST) reported disappointing third-quarter earnings, with earnings of 29 cents per share, missing the analyst estimate of 30 cents. Despite sales of $2.133 billion exceeding expectations, shares fell 3.9% to $44.00 in pre-market trading. Other stocks also declined, including Strive Inc (down 32.4%), Vince Holding Corp (down 8%), and Scholar Rock Holding Corp (down 6%). Overall, U.S. stock futures were higher, with Dow futures gaining around 400 points.
U.S. stock futures were higher this morning, with the Dow futures gaining around 400 points on Monday.
Shares of Fastenal Company (NASDAQ:FAST) fell sharply in pre-market trading following downbeat third-quarter earnings.
Fastenal reported quarterly earnings of 29 cents per share which missed the analyst consensus estimate of 30 cents per share. The company reported quarterly sales of $2.133 billion compared to the analyst consensus estimate of $2.129 billion.
Fastenal shares dipped 3.9% to $44.00 in pre-market trading.
Here are some other stocks moving lower in pre-market trading.
- Strive Inc (NASDAQ:ASST) shares tumbled 32.4% to $1.05 in pre-market trading after falling 14% on Friday.
- Super League Enterprise Inc (NASDAQ:SLE) declined 11.8% to $3.71 in pre-market trading. Super League Enterprise shares jumped 18% on Friday after the company announced a partnership with ES3.
- Vince Holding Corp (NYSE:VNCE) dipped 8% to $2.63 in pre-market trading. Vince announced that it will transfer to the Nasdaq from the NYSE.
- Scholar Rock Holding Corp (NASDAQ:SRRK) fell 6% to $37.13 in pre-market trading after declining 4% on Thursday.
- Advantage Solutions Inc (NASDAQ:ADV) declined 4.7% to $1.41 in pre-market trading.
- PepGen Inc (NASDAQ:PEPG) fell 4.6% to $4.50 in pre-market trading.
- JFrog Ltd (NASDAQ:FROG) declined 4.2% to $44.10 in pre-market trading.
- Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) fell 3.2% to $43.50 in pre-market trading. Crinetics Pharmaceuticals announced October inducement grants under Nasdaq Listing Rule 5635(c)(4).
Now Read This:
- Bank of America Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street’s Most Accurate Analysts
Photo via Shutterstock
